Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Urokinase-type plasminogen activator receptor: a beacon of malignancy?

Urokinase-type plasminogen activator receptor: a beacon of malignancy? Clin Cancer Res. 2008 Sep 15; 14(18):5643-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.